BIOMAT Database Logo BIOMAT Database Logo

Serum beta 2-microglobulin levels and p24 antigen, lymphocyte depletion and disease progression in human immunodeficiency virus infection. 1992

R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Servizio Speciale di Ematologia di Laboratorio, University of Napoli, Italy.

Abnormally elevated serum beta 2-microglobulin levels have been associated with progression of human immunodeficiency virus disease. In this study we have analyzed the relationship between serum beta 2-microglobulin levels of patients at different stages of the disease and serological and immunological parameters commonly used for monitoring the infection. The investigation was performed on 150 patients and 30 controls during the period from March 1989 to March 1990. At that time, 30 patients had the acquired immunodeficiency syndrome or its related complex and 120 had persistent generalized lymphadenopathy or were asymptomatic. Thirty-nine antibody-negative subjects, belonging to a high-risk group for the acquired immunodeficiency syndrome, were used as controls. All patients had normal renal function. There was a significant relationship between increased serum beta 2-microglobulin levels and the presence of p24 antigen, a decrease in the total number of lymphocytes (less than or equal to 1500/mm3) and a decrease in CD4+ T lymphocytes (less than or equal to 200/mm3). No significant relationship between serum beta 2-microglobulin levels and CD3+ T lymphocytes was found.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D015166 Monitoring, Immunologic Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc. Immune Monitoring,Immunologic Monitoring,Immunosurveillance,Monitoring, Immune,Monitoring, Radioimmunologic,Monitoring, Immunological,Monitoring, Radioimmunological,Radioimmunologic Monitoring,Immunological Monitoring,Radioimmunological Monitoring

Related Publications

R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Serum beta 2-microglobulin and human immunodeficiency virus infection.
July 1987, AIDS (London, England),
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection.
November 1988, Journal of clinical & laboratory immunology,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Sequential measurement of beta 2-microglobulin levels, p24 antigen levels, and antibody titers following transplantation of a human immunodeficiency virus-infected kidney allograft.
January 1991, Journal of acquired immune deficiency syndromes,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
BETA-2-MICROGLOBULIN LEVELS IN HUMAN-IMMUNODEFICIENCY VIRUS INFECTED SUBJECTS.
October 1997, Medical journal, Armed Forces India,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Beta-2-microglobulin concentrations in pediatric human immunodeficiency virus infection.
November 1990, The Pediatric infectious disease journal,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Racial differences in serum beta 2-microglobulin in persons with human immunodeficiency virus infection.
May 1993, The Journal of infectious diseases,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
March 1993, AIDS (London, England),
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
[Quantification of the levels of p24 antigen and antibodies in human immunodeficiency virus infection].
February 1992, Enfermedades infecciosas y microbiologia clinica,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
January 1994, International journal of clinical & laboratory research,
R Alfieri, and A Chirianni, and T Mancino, and P Remondelli, and P Russo, and G Liuzzi, and R Della Morte, and N Staiano
[Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
December 1992, Medicina clinica,
Copied contents to your clipboard!